Bank of America’s Blueprint Medicines BPMC Stock Holding History

Bank of America’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-25,000	Closed	-$1.26M	–	7843
2022 Q2	$1.26M	Buy	+25,000	New	+$1.46M	﹤0.01%	4697
2019 Q4	–	Sell	-144,300	Closed	-$10.6M	–	7090
2019 Q3	$10.6M	Buy	+144,300	New	+$12.5M	﹤0.01%	2449
2019 Q2	–	Sell	-22,500	Closed	-$1.8M	–	7181
2019 Q1	$1.8M	Hold	22,500	–	–	﹤0.01%	4072
2018 Q4	$1.21M	Sell	22,500 -15,000	-40%	-$912K	﹤0.01%	4246
2018 Q3	$2.93M	Hold	37,500	–	–	﹤0.01%	3659
2018 Q2	$2.38M	Buy	37,500 +7,500	+25%	+$597K	﹤0.01%	3838
2018 Q1	$2.75M	Buy	+30,000	New	+$2.59M	﹤0.01%	3626

Other funds holding BPMC

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bank of America's BPMC Position: Q3 2025 in Review

Bank of America sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 647,487 shares — an estimated $83M sold.

Bank of America first reported a position in BPMC in Q2 2015 and held it in 41 quarters. The position peaked at $83M in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

Bank of America reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
Bank of America sold 647,487 Blueprint Medicines shares in Q3 2025, an estimated $83M.
Bank of America first reported a position in Blueprint Medicines in Q2 2015 and held it in 41 quarters.
Bank of America's Blueprint Medicines position peaked at $83M in Q2 2025.
5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Bank of America's 13F filing for Q3 2025, filed 14 Nov 2025.